With an onslaught of Covid-19 cases from the Omicron variant looming, identifying treatments for Long Covid has become even more imperative. Since the beginning of the pandemic, Solve M.E. was one of the first organizations to recognize the emerging threat of the long-term debilitating outcomes of Covid-19. To that end, solve M.E. co-founded the Long COVID Alliance and helped secure over $1.15 billion for post-infection research.
As I’ve previously shared, the ME/CFS community has much wisdom and experience to offer those suffering from Long Covid, particularly the large number who have or will be diagnosed with ME/CFS. Our work in the post-infection disease space has allowed us to create and support research and advocacy programs that will improve outcomes for the millions suffering from poorly understood, chronic diseases.
That’s why we’re launching our Solve Long Covid Initiative to utilize over 30 years of our research and advocacy experience advancing the understanding of post-infection diseases. This initiative will allow us to continue to expand capacity and investment in programs such as the You + ME Registry, our federal advocacy, the Ramsay Research Grant Program, and more — strengthening our response to this emerging crisis while ensuring that progress made will benefit everyone with a “long haul” disease.
The tragic public health emergency of Long Covid has created a once-in-a-lifetime opportunity to address decades of neglect, raise awareness about ME/CFS, and make unprecedented progress in our search for treatments and cures for post-infection diseases. With the Solve Long Covid Initiative, we are seizing this moment. As we continue to expand our efforts, your voice matters. Stay tuned for more opportunities to get involved and to share your insights.
President and CEO
P.S. — As part of our efforts with the Solve Long Covid Initiative, we’re also partnering with the Global Interdependence Center on a year-long webinar and conference series exploring the pandemic’s long-term healthcare, policy, and economic impact. We’ll bring together world-class immunologists, medical experts, policymakers, and economists to explore critical insights into defining, diagnosing, optimizing treatments, and healthcare policies for Long Covid and post-infection diseases based on analyses of their impact on the U.S. and global labor markets.
We hope you’ll join us for the first webinar on January 6, 2022, which will include a presentation and Q & A session with myself, Emily Taylor (Solve M.E. Vice President of Advocacy and Community Relations), ME/CFS and Long Covid researcher Amy Proal, Ph.D., and others.